NASDAQ · Medical - Pharmaceuticals

Damora Therapeutics, Inc. (DMRA) Stock

$21.08 +2.53% NASDAQ: DMRA Healthcare

Valuation

MetricValue
Price$21.08
Market Cap$1.30B
P/E Ratio-0.17
P/B Ratio2.54
P/S Ratio0.00
EPS (TTM)$-2.44
52-Week High$38.33
52-Week Low$3.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-82.56%
ROA-48.35%
ROCE-52.44%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio12.98

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-52.0M$-61.0M$-36.0M$-17.0M$-211.0M
Net Profit$-52.0M$-62.0M$-38.0M$-21.0M$-210.0M
EPS$-51.22$-60.63$-36.08$-18.53$-152.99
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$122.0M$73.0M$38.0M$17.0M$261.0M
Total Liabilities$5.0M$11.0M$6.0M$3.0M$20.0M
Cash$63.0M$33.0M$21.0M$14.0M$258.0M
Borrowings$1.0M$1.0M$0$1.0M$0

Latest News

Damora Therapeutics Completes Redomestication to Cayman Islands MT Newswires · Jul 17, 2026 Damora Announces Redomestication from Delaware to Cayman Islands GlobeNewswire · Jul 17, 2026 Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 1, 2026 HC Wainwright Initiates Damora Therapeutics at Buy With $45 Price Target MT Newswires · Jun 11, 2026 TD Cowen Initiates Damora Therapeutics at Buy MT Newswires · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-52.0M$-43.0M$-37.0M$-19.0M$-7.0M
Investing Cash Flow$-48.0M$12.0M$22.0M$12.0M$-17.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-101.0M$-30.0M$-11.0M$-7.0M$243.0M
Free Cash Flow$-53.0M$-43.0M$-37.0M$-19.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.93
FCF Yield-3.17%
Quick Ratio19.73
Interest Coverage0.00
Return 1Y651.91%
Return 3Y-51.43%
Return 5Y-74.06%

Ownership

Insiders Held7.62%
Institutions Held94.05%
Institutions Float Held101.81%
Institutional HolderSharesReport Date
FMR, LLC9,045,4812026-03-31
Fairmount Funds Management LLC8,713,0002026-03-31
Avoro Capital Advisors LLC3,783,0002026-03-31
Venrock Adviser, LLC3,603,5952026-03-31
FCPM III Services B.V.2,441,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COAGHemab Therapeutics Holdings, Inc. Common Stock $31.62 +2.36% -24.14 $1.48B 0.00%
GERNGeron Corporation $1.23 +0.41% -12.04 $785.86M 0.00%
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
INCYIncyte Corporation $113.14 +0.35% 15.15 $22.93B 0.00%
IRONDisc Medicine, Inc. $62.16 +2.29% -9.92 $2.39B 0.00%

About Damora Therapeutics, Inc.

Damora Therapeutics, Inc. is led by CEO Jennifer A. Jarrett, employs 7 people, headquartered in US, publicly traded since 2026.

Damora Therapeutics, Inc. (DMRA) stock trades at $21.08 with a market capitalization of $1.30B. The stock is valued at a price-to-earnings (P/E) ratio of -0.17, price-to-book of 2.54, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.50 and $38.33, and currently trades 45.0% below its 52-week high.

On profitability, Damora Therapeutics, Inc. generates a return on equity (ROE) of -82.56%, return on capital employed of -52.44%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides